Molecular Diagnostics of Human Diseases

The analysis of high-dimensional and multimodal biomedical data has been suggested by a few machine learning advancements, which have improved the discovery, detection, and remedial checking of early infection movement. With advances in clinical epigenetics that distinguish Sirtuin 1 as deficient and to be associated with lethal invulnerable responses crucial to mitophagy, diagnostic testing and plasma analyte examination cannot determine atomic mitochondria deficiencies. To determine the significance of symptomatic clinical biochemistry tests, sirtuin analysis in plasma and body fluids is essential. This will enable the early diagnosis of diseases such as cardiovascular diseases, non-alcoholic fatty liver infection, metabolic diseases, and neurodegenerative diseases. Doctors are concerned about the under diagnosis of numerous chronic diseases that are linked to diabetes and organ disorders around the world and the speed at which modified cell death is increasing.

  • Bioinformatics
  • Microarray

Related Conference of Molecular Diagnostics of Human Diseases

June 23-24, 2025

10th World Congress on Internal Medicine and Primary Care

Aix-en-Provence, France

Molecular Diagnostics of Human Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in